157 related articles for article (PubMed ID: 30943928)
41. [Predictive and prognostic value of MSI phenotype in adjuvant colon cancer: Who and how to treat?].
Zaanan A; Taieb J
Bull Cancer; 2019 Feb; 106(2):129-136. PubMed ID: 30527814
[TBL] [Abstract][Full Text] [Related]
42. [Pancreatoduodenectomy for locally advanced ascending colon cancer after neoadjuvant chemotherapy (mFOLFOX6)].
Oono R; Enomoto N; Hosoya N; Ueda Y; Otsuki S; Motoyama K
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1529-31. PubMed ID: 21918356
[TBL] [Abstract][Full Text] [Related]
43. Oral tegafur-uracil as metronomic therapy following intravenous FOLFOX for stage III colon cancer.
Huang WY; Ho CL; Lee CC; Hsiao CW; Wu CC; Jao SW; Yang JF; Lo CH; Chen JH
PLoS One; 2017; 12(3):e0174280. PubMed ID: 28328969
[TBL] [Abstract][Full Text] [Related]
44. Prognostic value of positron emission tomography/computed tomography for adjuvant chemotherapy of colon cancer.
Baik H; Lee SM; Seo SH; An MS; Kim KH; Bae KB; Oh MK; Hong KH
ANZ J Surg; 2018 Jun; 88(6):587-591. PubMed ID: 28687025
[TBL] [Abstract][Full Text] [Related]
45. Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX).
Kim JE; Hong YS; Kim HJ; Kim KP; Kim SY; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Kim JH; Kim TW
Ann Surg Oncol; 2017 May; 24(5):1289-1294. PubMed ID: 27853901
[TBL] [Abstract][Full Text] [Related]
46. Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer.
Huang CM; Huang MY; Ma CJ; Yeh Y-; Tsai HL; Huang CW; Huang CJ; Wang JY
Radiat Oncol; 2017 Mar; 12(1):48. PubMed ID: 28270172
[TBL] [Abstract][Full Text] [Related]
47. Prognostic factor analysis of circulating tumor cells in peripheral blood of patients with peritoneal carcinomatosis of colon cancer origin treated with cytoreductive surgery plus an intraoperative hyperthermic intraperitoneal chemotherapy procedure (CRS + HIPEC).
Melero JT; Ortega FG; Gonzalez AM; Carmona-Saez P; Garcia Puche JL; Sugarbaker PH; Delgado M; Lorente JA; Serrano MJ
Surgery; 2016 Mar; 159(3):728-35. PubMed ID: 26518392
[TBL] [Abstract][Full Text] [Related]
48. Blood neutrophil-lymphocyte ratio predicts survival in locally advanced cancer stomach treated with neoadjuvant chemotherapy FOLFOX 4.
el Aziz LM
Med Oncol; 2014 Dec; 31(12):311. PubMed ID: 25367855
[TBL] [Abstract][Full Text] [Related]
49. Clinical Evaluation of Preoperative Radiotherapy Combined with FOLFOX Chemotherapy on Patients with Locally Advanced Colon Cancer.
Zhou J; Guo Z; Yu W; Li S; Qiao W
Am Surg; 2019 Apr; 85(4):313-320. PubMed ID: 31043188
[TBL] [Abstract][Full Text] [Related]
50. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
Ejaz A; Casadaban L; Maker AV
J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
[TBL] [Abstract][Full Text] [Related]
51. Detection of Circulating Tumor Cells in Locally Advanced High-risk Prostate Cancer During Neoadjuvant Chemotherapy and Radical Prostatectomy.
Thalgott M; Rack B; Horn T; Heck MM; Eiber M; Kübler H; Retz M; Gschwend JE; Andergassen U; Nawroth R
Anticancer Res; 2015 Oct; 35(10):5679-85. PubMed ID: 26408743
[TBL] [Abstract][Full Text] [Related]
52. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy.
Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C
Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771
[TBL] [Abstract][Full Text] [Related]
53. Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.
Schmoll HJ; Tabernero J; Maroun J; de Braud F; Price T; Van Cutsem E; Hill M; Hoersch S; Rittweger K; Haller DG
J Clin Oncol; 2015 Nov; 33(32):3733-40. PubMed ID: 26324362
[TBL] [Abstract][Full Text] [Related]
54. [Adjuvant and palliative anticancer treatment of colon carcinoma in 2004].
Medinger M; Steinbild S; Mross K
Praxis (Bern 1994); 2004 Sep; 93(40):1633-44. PubMed ID: 15495753
[TBL] [Abstract][Full Text] [Related]
55. [Adjuvant therapy for colon cancer].
Lordick F; Rosenberg R; Stein HJ; Peschel C; Siewert JR
Dtsch Med Wochenschr; 2004 Oct; 129(44):2366-71. PubMed ID: 15497107
[No Abstract] [Full Text] [Related]
56. The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer.
Zhou J; Dong F; Cui F; Xu R; Tang X
Cancer Chemother Pharmacol; 2017 Apr; 79(4):825-833. PubMed ID: 28289866
[TBL] [Abstract][Full Text] [Related]
57. Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial).
Kotaka M; Yoshino T; Oba K; Shinozaki K; Touyama T; Manaka D; Matsui T; Ishigure K; Hasegawa J; Inoue K; Goto K; Sakamoto J; Saji S; Ohtsu A; Watanabe T
Cancer Chemother Pharmacol; 2015 Jul; 76(1):75-84. PubMed ID: 25983021
[TBL] [Abstract][Full Text] [Related]
58. Cost-effectiveness of adjuvant FOLFOX therapy for stage III colon cancer in Japan based on the MOSAIC trial.
Shiroiwa T; Takeuchi T; Fukuda T; Shimozuma K; Ohashi Y
Value Health; 2012; 15(2):255-60. PubMed ID: 22433756
[TBL] [Abstract][Full Text] [Related]
59. Prognostic Significance of Lymphocyte Counts in Colon Cancer Patients Treated with FOLFOX Chemotherapy.
Noh OK; Oh SY; Kim YB; Suh KW
World J Surg; 2017 Nov; 41(11):2898-2905. PubMed ID: 28707088
[TBL] [Abstract][Full Text] [Related]
60. The efficacy of chemotherapy in patients with high-grade metastatic colon cancer.
Liu CJ; Lin JK; Chen WS; Lin TC; Yang SH; Jiang JK; Chang SC; Lan YT; Yen CC; Tzeng CH; Wang HW; Teng HW
Hepatogastroenterology; 2011; 58(110-111):1495-501. PubMed ID: 21940314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
